These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15239662)

  • 21. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
    Wu W; Borch RF
    Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel cyclopropapyrroloindole derivative (AT-3510) bearing methoxycarbonyl and trifluoromethyl groups.
    Fukuda Y; Furuta H; Kusama Y; Ebisu H; Oomori Y; Terashima S
    J Med Chem; 1999 Apr; 42(8):1448-58. PubMed ID: 10212131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer.
    Zhao RY; Erickson HK; Leece BA; Reid EE; Goldmacher VS; Lambert JM; Chari RV
    J Med Chem; 2012 Jan; 55(2):766-82. PubMed ID: 22148292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,2-benzisoxazole phosphorodiamidates as novel anticancer prodrugs requiring bioreductive activation.
    Jain M; Kwon CH
    J Med Chem; 2003 Dec; 46(25):5428-36. PubMed ID: 14640551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
    Gerard Y; Voissière A; Peyrode C; Galmier MJ; Maubert E; Ghedira D; Tarrit S; Gaumet V; Canitrot D; Miot-Noirault E; Chezal JM; Weber V
    Bioorg Chem; 2020 May; 98():103747. PubMed ID: 32208207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustards.
    Springer JB; Chang YH; Koo KI; Colvin OM; Colvin ME; Dolan ME; Delaney SM; Flowers JL; Ludeman SM
    Chem Res Toxicol; 2004 Sep; 17(9):1217-26. PubMed ID: 15377155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of mercapto triazolo-benzothiadiazine linked aminobenzothiazoles as potential anticancer agents.
    Kamal A; Khan MN; Srikanth YV; Rajesh SV
    Chem Biol Drug Des; 2009 Jun; 73(6):687-93. PubMed ID: 19635062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and biological evaluation of (E)-styrylbenzylsulfones as novel anticancer agents.
    Reddy MV; Mallireddigari MR; Cosenza SC; Pallela VR; Iqbal NM; Robell KA; Kang AD; Reddy EP
    J Med Chem; 2008 Jan; 51(1):86-100. PubMed ID: 18088089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities.
    Argade AB; Devraj R; Vroman JA; Haugwitz RD; Hollingshead M; Cushman M
    J Med Chem; 1998 Aug; 41(18):3337-46. PubMed ID: 9719586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in vivo antitumor evaluation of 2-methoxyestradiol 3-phosphate, 17-phosphate, and 3,17-diphosphate.
    Edsall AB; Agoston GE; Treston AM; Plum SM; McClanahan RH; Lu TS; Song W; Cushman M
    J Med Chem; 2007 Dec; 50(26):6700-5. PubMed ID: 18052315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of cryptolepine analogues as potential bioreducible anticancer agents.
    Seville S; Phillips RM; Shnyder SD; Wright CW
    Bioorg Med Chem; 2007 Oct; 15(19):6353-60. PubMed ID: 17643990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of peptide conjugates of phosphoramide mustard as prodrugs activated by prostate-specific antigen.
    Wu X; Hu L
    Bioorg Med Chem; 2016 Jun; 24(12):2697-706. PubMed ID: 27156193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphorase.
    Flader C; Liu J; Borch RF
    J Med Chem; 2000 Aug; 43(16):3157-67. PubMed ID: 10956224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
    Waern JB; Dillon CT; Harding MM
    J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents.
    Kwon CH; Moon KY; Baturay N; Shirota FN
    J Med Chem; 1991 Feb; 34(2):588-92. PubMed ID: 1995881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antitumor activity of CBI-bearing ester and carbamate prodrugs of CC-1065 analogue.
    Wang Y; Li L; Tian Z; Jiang W; Larrick JW
    Bioorg Med Chem; 2006 Dec; 14(23):7854-61. PubMed ID: 16908174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological activity of protaxols.
    Nicolaou KC; Riemer C; Kerr MA; Rideout D; Wrasidlo W
    Nature; 1993 Jul; 364(6436):464-6. PubMed ID: 8101355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.